Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

140
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
140
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

139
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
139
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

223
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
223
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

817
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
817
Study Design in Statistics01:15

Study Design in Statistics

9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Testing a Claim about Standard Deviation01:19

Testing a Claim about Standard Deviation

2.9K
A complete procedure to test a claim about population standard deviation or population variance is explained here.
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An exploratory analysis of interaction effects in EQ-5D valuation using saturated EQ VAS datasets from the Netherlands, the United Kingdom, and China.

Health and quality of life outcomes·2026
Same author

Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients.

PharmacoEconomics·2026
Same author

Anxiety and depression may amplify self-reported physical health problems: evidence from EQ-5D-5L data.

Health and quality of life outcomes·2026
Same author

HRQoL in Adolescents with Idiopathic Isolated GHD: rhGH (Dis)continuation in Mid-Puberty.

Endocrine connections·2026
Same author

Valuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Developing a quality of life framework from the perspective of laypeople: a qualitative comparison with the EQ-HWB framework.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2025

Related Experiment Video

Updated: Jan 4, 2026

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
10:39

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning

Published on: August 29, 2025

961

Toward a Smaller Design for EQ-5D-5L Valuation Studies.

Zhihao Yang1, Nan Luo2, Mark Oppe3

  • 1College of Pharmacy, Jinan University, Guangzhou, China; Medical Psychology and Psychotherapy, Erasmus Medical Center, Rotterdam, the Netherlands.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|November 12, 2019
PubMed
Summary

Smaller health state valuation designs are effective for time trade-off (TTO) data, showing minimal prediction errors. This offers a cost-effective alternative for resource-limited countries conducting health valuation studies.

Keywords:
EQ-5D-5LTTOsmall designvaluation

More Related Videos

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.8K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.0K

Related Experiment Videos

Last Updated: Jan 4, 2026

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
10:39

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning

Published on: August 29, 2025

961
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.8K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.0K

Area of Science:

  • Health Economics
  • Psychometrics
  • Decision Science

Background:

  • The EuroQol Group uses the EuroQol Valuation Technology (EQ-VT) protocol with composite time trade-off (cTTO) to value 86 health states for EQ-5D-5L.
  • This standard approach models observed values to generate utility values for all 3125 possible health states.

Purpose of the Study:

  • To evaluate if a smaller, 25-state orthogonal design could accurately predict health state utilities using time trade-off (TTO) data.
  • To compare the predictive accuracy of TTO data using standard EQ-VT, orthogonal, and D-efficient designs.

Main Methods:

  • Collected TTO values from 525 university students using EQ-PVT software for EQ-VT, orthogonal, and D-efficient designs.
  • Each design involved valuing a random block of health states, with 100 observations per state.
  • Modeled TTO data by design and compared root mean square error (RMSE) between observed and predicted values.

Main Results:

  • The standard EQ-VT design yielded the lowest RMSE (0.052).
  • Orthogonal and D-efficient designs showed slightly higher RMSEs (0.066 and 0.063, respectively).
  • Prediction errors varied for more severe health states, and some model coefficients differed across designs.

Conclusions:

  • Smaller valuation designs, like the 25-state orthogonal or D-efficient designs, do not significantly increase prediction errors for TTO data.
  • These smaller designs present a viable, resource-efficient option for health state valuation studies, particularly in resource-constrained settings.
  • Smaller designs can be integrated with other preference data, such as discrete choice experiments, for joint modeling.